2333 Trastuzumab in combination with different first-line chemotherapies for treatment of HER2-positive metastatic gastric or gastro- oesophageal junction cancer: Updated findings from the German non-interventional study HerMES. (September 2015) - Al-Batran, S.E.; Kroening, H.; Hannig, C.V.; Hamm, T.; Moorahrend, E.; Petersen, V.; Eggers, E.; Hempel, D.; Zielke, K.; Thuss-Patience, P.; Moehler, M.; Hegewisch-Becker, S.